Prevalence of Long COVID Syndrome and Its Association With Blood Group: A Cross-Sectional Study

February 2024 in “ Curēus ”

Muhammad Butt, Muhammad Abdullah, Mustafa Waseem, Hamna Ahmed, Azizul Hasan Aamir, Asif Rizwan, Hameed Mumtaz Durrani

TLDR Long COVID is more common in those with severe initial infections, but not linked to blood group.

This study analyzed the prevalence of Long COVID and its association with blood group among 196 participants in Islamabad. The majority of participants experienced acute symptoms, with fatigue being the most persistent. After four weeks, 63.3% reported new symptoms like hair loss. Females were more likely to experience Long COVID symptoms, which were significantly associated with the perceived severity of the acute infection. However, no association was found between Long COVID and blood group. The findings suggest that those with severe acute infections are more likely to develop Long COVID, indicating a need for further research on early aggressive care.

View this study on assets.cureus.com →

Discuss this study in the Community →

Similar Research

6 / 1000+ results

research Towards a Molecular Understanding of Hair Loss and Its Treatment

236 citations, July 2001 in “Trends in Molecular Medicine”

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

research Female Pattern Hair Loss

226 citations, September 2001 in “Journal of The American Academy of Dermatology”

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

research A Randomized, Placebo-Controlled Trial of 5% and 2% Topical Minoxidil Solutions in the Treatment of Female Pattern Hair Loss

219 citations, March 2004 in “Journal of The American Academy of Dermatology”

5% and 2% minoxidil solutions effectively promote hair growth and reduce hair loss, with 5% being slightly more effective but having more side effects.

The Importance of Dual 5α-Reductase Inhibition in the Treatment of Male Pattern Hair Loss: Results of a Randomized Placebo-Controlled Study of Dutasteride Versus Finasteride

research The Importance of Dual 5α-Reductase Inhibition in the Treatment of Male Pattern Hair Loss: Results of a Randomized Placebo-Controlled Study of Dutasteride Versus Finasteride

215 citations, November 2006 in “Journal of The American Academy of Dermatology”

Dutasteride more effective for hair growth, but has more side effects than finasteride.

research The Diagnosis and Treatment of Iron Deficiency and Its Potential Relationship to Hair Loss

207 citations, April 2006 in “Journal of The American Academy of Dermatology”

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

research Prevalence of Male and Female Pattern Hair Loss in Maryborough

193 citations, August 2005 in “Journal of Investigative Dermatology Symposium Proceedings”

Hair loss common in Australia; men affected earlier, more often than Asians; women less concerned.

Prevalence of Long COVID Syndrome and Its Association With Blood Group: A Cross-Sectional Study

Related Community Posts Join

community How does hair loss and recovery work?

community Hair loss products whilst trying to conceive

community Hair loss treatment tier list by Dr Oscar Muñoz

community Hair Loss transformation Min/Fin/DermaStamp Age 23 M.

community Best hair loss treatment to get your hair back!

community Hair Loss Associated with Escitalopram (anti-depressant). Do SSRIs Affect the Hair Follicle?